Skip to main content

Sphingosine Kinase 1/SPHK1 Products

Sphingosine kinases are cytosolic or membrane-associated enzymes that catalyze the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P). Two types of sphingosine kinases, SPHK1 and SPHK2, are known to be expressed in human cells. The two enzymes share considerable amino acid sequence similarity, but differ in their N-terminal and central regions. The two proteins also differ in tissue distribution and some kinetic properties. S1P is a lipid messenger that regulates diverse physiological processes including cell proliferation, migration, apoptosis, inflammation, calcium homeostasis and cytoskeletal structure. The level of S1P is tightly controlled by SPHKs and S1P degrading enzymes. SPHK1 and its activation can be stimulated by several growth factors such as tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-beta. Expression of SPHK1 has been found to increase in many human solid tumors and overexpression of SPHK1 is associated with tumor angiogenesis. Such studies have implicated SPHK1 as a new target for cancer treatment.

Show More

61 results for "Sphingosine Kinase 1/SPHK1" in Products

61 results for "Sphingosine Kinase 1/SPHK1" in Products

Sphingosine Kinase 1/SPHK1 Products

Sphingosine kinases are cytosolic or membrane-associated enzymes that catalyze the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P). Two types of sphingosine kinases, SPHK1 and SPHK2, are known to be expressed in human cells. The two enzymes share considerable amino acid sequence similarity, but differ in their N-terminal and central regions. The two proteins also differ in tissue distribution and some kinetic properties. S1P is a lipid messenger that regulates diverse physiological processes including cell proliferation, migration, apoptosis, inflammation, calcium homeostasis and cytoskeletal structure. The level of S1P is tightly controlled by SPHKs and S1P degrading enzymes. SPHK1 and its activation can be stimulated by several growth factors such as tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-beta. Expression of SPHK1 has been found to increase in many human solid tumors and overexpression of SPHK1 is associated with tumor angiogenesis. Such studies have implicated SPHK1 as a new target for cancer treatment.

Show More
Applications: IHC, WB, ELISA, ICC/IF
Reactivity: Human
Applications: WB, ICC/IF, IP
Reactivity: Human, Rat
Applications: IHC, WB, ICC/IF
Reactivity: Human, Rat, Monkey
Applications: EnzAct
Applications: IHC
Reactivity: Human, Monkey
Applications: IHC, WB, Flow
Reactivity: Human

Recombinant Monoclonal Antibody.

Applications: WB, ICC/IF
Reactivity: Human
Applications: WB, ICC/IF, IP
Reactivity: Human, Rat
Applications: WB, ELISA
Reactivity: Human, Mouse, Rat, Bovine
Applications: WB
Applications: IP
Reactivity: Human
Applications: WB, ICC/IF, IP
Reactivity: Human, Rat
Applications: WB, ICC/IF, IP
Reactivity: Human, Rat
Applications: IHC, WB, ICC/IF
Reactivity: Human, Rat, Monkey
Applications: IHC, WB, ICC/IF
Reactivity: Human, Rat, Monkey
Applications: WB, ELISA, IHC, IP, ICC
Reactivity: Human
Applications: ELISA
Reactivity: Human
Applications: ICC
Reactivity: Human

Selective non-lipid inhibitor of sphingosine kinase

Applications: IHC, WB, ICC/IF
Reactivity: Human, Rat, Monkey
Applications: IHC, WB, ICC/IF
Reactivity: Human, Rat, Monkey
Applications: IHC, WB, ICC/IF
Reactivity: Human, Rat, Monkey
Results Per Page
5 10 25 50
/ 3